Journal article
Tenofovir disoproxil fumarate fails to prevent HIV acquisition or the establishment of a viral reservoir: two case reports
- Abstract:
-
The use of antiretrovirals as pre-exposure prophylaxis (PrEP) is highly efficacious in HIV prevention. The World Health Organization recently recommended Truvada(®) (Gilead Sciences, Inc.) or tenofovir disoproxil fumarate (TDF) for high-risk individuals, with limited data for single-agent TDF PrEP in men who have sex with men (MSM). We report two cases of TDF PrEP failure in MSM who had received long-term TDF for hepatitis B infection and had therapeutic levels of drug immediately after HIV a...
Expand abstract
- Publication status:
- Published
- Peer review status:
- Peer reviewed
Actions
Authors
Bibliographic Details
- Publisher:
- Springer Healthcare Publisher's website
- Journal:
- Infectious diseases and therapy Journal website
- Volume:
- 5
- Issue:
- 1
- Pages:
- 65-71
- Publication date:
- 2016-01-09
- DOI:
- EISSN:
-
2193-6382
- ISSN:
-
2193-8229
- Source identifiers:
-
587536
Item Description
- Language:
- English
- Keywords:
- Pubs id:
-
pubs:587536
- UUID:
-
uuid:7d0fd7c2-dd01-475a-b9fd-ea3f557da2db
- Local pid:
- pubs:587536
- Deposit date:
- 2016-06-28
Terms of use
- Copyright holder:
- Julie Fox et al
- Copyright date:
- 2016
- Notes:
- This article is distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 International License (http://creativecommons.org/licenses/by-nc/4.0/), which permits any noncommercial use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made.
If you are the owner of this record, you can report an update to it here: Report update to this record